Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/22/2012CN101612147B Application of alpha-mangostin in preparing inflammation-resisting pain-relieving medicine
08/22/2012CN101591280B Retinoids with effect of induction of differentiation of tumors and pharmaceutical composition as well as application thereof
08/22/2012CN101590127B Compound medicine containing total flavone of hawthorn (leaf) and folic acid compound
08/22/2012CN101590125B Medicament for treating empyrosis and using method thereof
08/22/2012CN101585835B Preparation method and application of bencycloquidium bromide optical isomer and composition of bencycloquidium bromide optical isomer
08/22/2012CN101569748B Water-soluble taxol prodrug prodrug preparation method
08/22/2012CN101569747B Preparation method of taxol prodrug using polyethylene glycol as carrier
08/22/2012CN101524305B Far-infrared pain-relieving magnetic therapy patch
08/22/2012CN101522700B Novel morphine derivatives
08/22/2012CN101518530B Stable solid composite medicament of compound penicillin
08/22/2012CN101506179B Method of dynamic nuclear polarisation (DNP) and compounds and compositions for use in the method
08/22/2012CN101506159B Compounds having CRTH2 antagonist activity
08/22/2012CN101485751B Cotinus coggygria compound preparation and use
08/22/2012CN101485655B Application of dihydromyricetin in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy
08/22/2012CN101480405B Oryzanol composition and preparation method thereof
08/22/2012CN101474183B Preparation method of targeting antineoplastic medicine nitidine chloride complexes, product thereof and injection containing the product
08/22/2012CN101437793B Crystalline (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone phosphate
08/22/2012CN101389343B Doxorubicin formulations for anti-cancer use
08/22/2012CN101346346B Amine compound and use thereof for medical purposes
08/22/2012CN101327286B Pain-relieving anti-inflammation medicament and preparation method thereof and use
08/22/2012CN101310768B Medicine composition for treating hepatic disease and use thereof
08/22/2012CN101300253B Bicyclic derivatives as modulators of voltage gated ion channels
08/22/2012CN101298426B Water-soluble derivate of 2,6-diisopropyl phenol and use thereof
08/22/2012CN101291947B Crystalline forms of macrolide compounds endowed with antiinflammatory activity
08/22/2012CN101268054B Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, pharmaceutical compositions and therapeutic use
08/22/2012CN101259140B Compound medicaments treating gastritis, gastric ulcer, and duodenal ulcer and preparation thereof
08/22/2012CN101247801B Composition for prevention of increase in blood alcohol level
08/22/2012CN101228884B Biocidal polystyrene hydantoin particles
08/22/2012CN101167724B Application of medicinal composition containing amlodipine in preparing medicine for treating lower urinary tract disease
08/22/2012CN101123965B Methylphenidate derivatives and uses of methylphenidate derivatives
08/22/2012CN101062925B Paclitaxel derivatives, preparation method and medicinal composition and usage thereof
08/22/2012CN101014610B 15beta-substituted steroids having selective estrogenic activity
08/21/2012USRE43596 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
08/21/2012US8247610 Amine linked modulators of γ-secretase
08/21/2012US8247609 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors
08/21/2012US8247608 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors
08/21/2012US8247603 Deuterated catecholamine derivatives and medicaments comprising said compounds
08/21/2012US8247602 Antagonists of prostaglandin D2 receptors
08/21/2012US8247576 Pyrazole derivatives as protein kinase modulators
08/21/2012US8247573 Substituted N-(2-mercaptopyridin-3-yl)amides as KCNQ2/3 modulators
08/21/2012US8247572 Facilitated transport of bisphosphonates by vitamin C
08/21/2012US8247565 Sirtuin modulating compounds
08/21/2012US8247564 Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity
08/21/2012US8247563 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one ; for therapy of Alzheimer's disease, myasthenia gravis, Huntingtons disease or glaucoma
08/21/2012US8247562 Benzamide derivatives useful as histone deacetylase inhibitors
08/21/2012US8247552 Analogs of dehydrophenylahistins and their therapeutic use
08/21/2012US8247550 Certain substituted amides, method of making, and method of use thereof
08/21/2012US8247461 Ophthalmic and contact lens solution
08/21/2012US8247460 Method of treatment for muscular dystrophy
08/21/2012US8247459 Oil formulations
08/21/2012US8247458 Therapeutic agent for diabetic neuropathy
08/21/2012US8247457 Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
08/21/2012US8247456 Dosing regimes for trans-clomiphene
08/21/2012US8247455 Guanylhydrazone compounds, compositions, methods of making and using
08/21/2012US8247454 Liquid antibacterial compositions incorporating trichlorocarbanilide with reduced water activity
08/21/2012US8247453 Methods for the treatment of dermatological disorders
08/21/2012US8247452 Urea- and urethane-substituted acylureas, process for their preparation and their use
08/21/2012US8247451 ADAM10 and its uses related to infection
08/21/2012US8247450 Linoleic acid active agents for enhancing probability of becoming pregnant
08/21/2012US8247449 Methods and compositions for the treatment of asthma
08/21/2012US8247448 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
08/21/2012US8247445 Platinum complexes and methods of use
08/21/2012US8247444 Anti-tumor effect of dimeric phthalide compound
08/21/2012US8247443 Small molecule antagonists of bacterial quorum-sensing receptors
08/21/2012US8247442 Benzenesulfonamide compounds and their use
08/21/2012US8247441 Chromene compounds, a process for their preparation and pharmaceutical compositions containing them
08/21/2012US8247440 Composition comprising omeprazole, lansoprazole and at least one buffering agent
08/21/2012US8247439 Jasmonate derivatives, pharmaceutical compositions and methods of use thereof
08/21/2012US8247438 Methods for treating schizophrenia
08/21/2012US8247437 N-hydroxyamide derivatives and use thereof
08/21/2012US8247436 Pyridine and pyrazine derivative for the treatment of CF
08/21/2012US8247435 Formulations for treating human and animal diseases
08/21/2012US8247434 Fexofenadine polymorphs and processes of preparing the same
08/21/2012US8247433 Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
08/21/2012US8247432 Tripeptidyl peptidase inhibitors
08/21/2012US8247430 Substituted aryl-amine derivatives and methods of use
08/21/2012US8247429 Tricyclic compound and pharmaceutical use thereof
08/21/2012US8247428 Indole alkaloid derivatives having opioid receptor agonistic effect, and therapeutic compositions and methods relating to same
08/21/2012US8247427 Dual phase drug release system
08/21/2012US8247426 Crystalline irinotecan hydrochloride and methods for its preparation
08/21/2012US8247425 Peripheral opioid receptor antagonists and uses thereof
08/21/2012US8247424 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
08/21/2012US8247423 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
08/21/2012US8247422 Use of condensed pyrimidine derivatives for the treatment of rheumatoid arthritis
08/21/2012US8247420 Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
08/21/2012US8247419 Methods of identifying and treating individuals exhibiting mutant kit protein
08/21/2012US8247418 Pyrazine compounds as phosphodiesterase 10 inhibitors
08/21/2012US8247417 Methods of treatment of chronic pain using eszopiclone
08/21/2012US8247416 Phthalazinone derivative
08/21/2012US8247415 Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
08/21/2012US8247414 Pyridizinone derivatives and the use thereof as H3 inhibitors
08/21/2012US8247413 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity
08/21/2012US8247412 Urea derivatives methods for their manufacture and uses thereof
08/21/2012US8247411 Sulfonyl amide derivatives for the treatment of abnormal cell growth
08/21/2012US8247410 Pyrimidine substituted purine derivatives
08/21/2012US8247409 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
08/21/2012US8247408 Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer
08/21/2012US8247407 Pharmaceutical composition with anti-diabetic action
08/21/2012US8247406 Composition and method for treatment of MRSA
08/21/2012US8247405 Skin lightening compositions with acetylcholinesterase inhibitors
1 ... 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 ... 7860